Ongoing research into AI agent framework security identified an exploit chain in AutoGen Studio (AutoGen’s open-source prototyping user interface) that allows untrusted web content rendered by a ...

Island found dormant JavaScript injection paths in Adblock for YouTube, a Chrome extension with 10M+ installs, raising ...

In this tutorial, you'll learn how to generate scannable barcodes in Excel in two simple steps. You will also learn how to create random barcodes. A barcode is a machine-readable representation of ...

Barcodes are used in everything from inventory systems to billing tools. In this guide, Bhavin walks you through building a barcode generator using JavaScript that runs entirely in the browser. You’ll ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Across our lifespan, cells divide and differentiate to create the functional units of all organs, yet with age and cancer a small number of cellular families (clones) will rule the fate of the ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

The viral magnetic cat-eye nail effect opened up a whole new world of opportunity for nail art: They catch the light in a way that gives nail designs a sense of fluid motion. This gives circular ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...